Annual Impact Report

NICA’s success lies in aligning its day-to-day operations with our members’ passion for helping people, their challenges in supporting their communities, commitment to ensuring that infusion center capacity can keep pace with innovation, and our communities’ demands for access to the right drug at the right time.  This Executive Summary and expanded report is intended to provide insight into the work NICA does on behalf of the nation’s infusion centers and the people they serve.

Media Kit

The National Infusion Center Association (NICA) offers this kit with basic information about our organization for use by infusion centers and media or other press organizations.

Read more about NICA in our latest press mentions.

Would you like to mention us or include NICA resources in your upcoming article or write-up?

Please email our Communications team with your inquiry. Contact [email protected]

Press Release

The National Infusion Center Association (NICA) announces its collaboration with COSACO, a community health organization based in Puerto Rico, to improve access to COVID-19 monoclonal antibody therapies (CmAbs) for Puerto Ricans and Latinx Americans. COSACO is the Puerto Rico Community Health Coalition.

National Public Radio, npr.org

“Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients” 

This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her case of COVID-19. The interviewer lists our COVID-19 Antibody Therapy Locator as a tool that links those in need to infusion clinics offering antibody therapies. Note: This article has been syndicated to several local NPR branches’ websites.

Renal & Urology News, renalandurologynews.com

“Q&A: Monoclonal Antibodies for COVID-19”

In this Q&A interview with Jason C. Gallagher, PharmD, Clinical Professor and Clinical Specialist at Temple University, NICA is mentioned as a resource for patient education for COVID-19 monoclonal antibodies.

Yahoo Finance, finance.yahoo.com

“Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses”

This article, published January 12th, 2021, announces that the U.S. government has said it will continue to coordinate allocation of the antibody cocktail to state and territorial health departments. Our locator site is listed as a tool for patients, caregivers and healthcare providers can use to find sites with COVID-19 antibody treatments.

Ventura County Star, vcstar.com

“Experimental COVID-19 treatment aimed at keeping Ventura County residents out of hospitals”

NICA President and CEO, Brian Nyquist, is quoted in this article expressing the importance of COVID-positive patients receiving treatment in a timely manner, and the NICA COVID-19 Antibody Treatment locator is linked.

Cision® PR Newswire, prnewswire.com

“Powerful New Tool Predicts COVID Trends”

This article explores predictive analytics for predicting COVID-19 surges, and NICA is mentioned as one of the organizations helping to offer resources to locate treatment sites.

YakTriNews (Washington, KAPP/KVEW TV) yaktrinews.com

“Lower valley hospital sees success with COVID-19 antibody treatments”

This article explains how one local hospital in Sunnyside, Washington successful administered monoclonal antibodies to COVID-positive patients. Our NICA COVID-19 Antibody Treatment Locator is mentioned as a helpful resource used by patients to find treatment locations near them.

BioSpace, biospace.com

“NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression”

This article mentions that under the EUA, REGEN-COV is available throughout the U.S. and information on availability can be found through us!

Policy & Medicine, policymed.com

“High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression Online Live CME Accredited Webinars”

This article mentions NICA as a key resource for clinicians looking to learn more about monoclonal antibody therapies that have been granted Emergency Use Authorization (EUA) to prevent the need for hospitalization in high-risk outpatients who have COVID-19.

KIRO 7 Seattle News, kiro7.com

“COVID antibody treatments going unused in WA state as hospitals fill up, DOH says”

As pandemic-related hospitalizations increase as a result of the Delta-variant of COVID-19, the Washington State Department of Health notices that thousands of doses of monoclonal antibody therapies have gone unused. NICA’s CmAb locator is mentioned as a resource for those trying to find care sites to administer CmAbs.